Equities

Japan Animal Referral Medical Center Co Ltd

6039:TYO

Japan Animal Referral Medical Center Co Ltd

Actions
Consumer DiscretionaryConsumer Services
  • Price (JPY)2,230.00
  • Today's Change-9.00 / -0.40%
  • Shares traded1.50k
  • 1 Year change+28.09%
  • Beta0.9719
Data delayed at least 20 minutes, as of Nov 26 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in JPYIncome statement in JPYView more

Year on year Japan Animal Referral Medical Center Co Ltd's net income fell -11.41% from 380.66m to 337.22m despite revenues that grew 10.26% from 3.87bn to 4.27bn. An increase in the cost of goods sold as a percentage of sales from 62.74% to 65.71% was a component in the falling net income despite rising revenues.
Gross margin35.66%
Net profit margin9.93%
Operating margin14.06%
Return on assets5.60%
Return on equity12.50%
Return on investment6.51%
More ▼

Cash flow in JPYView more

In 2024, cash reserves at Japan Animal Referral Medical Center Co Ltd fell by 478.40m. However, the company earned 899.78m from its operations for a Cash Flow Margin of 21.07%. In addition the company used 985.86m on investing activities and also paid 392.32m in financing cash flows.
Cash flow per share374.77
Price/Cash flow per share6.40
Book value per share1,497.49
Tangible book value per share1,297.20
More ▼

Balance sheet in JPYView more

Japan Animal Referral Medical Center Co Ltd has a Debt to Total Capital ratio of 49.64%, a lower figure than the previous year's 92.01%.
Current ratio1.06
Quick ratio0.9748
Total debt/total equity0.9858
Total debt/total capital0.4964
More ▼

Growth rates in JPY

Year on year, growth in earnings per share excluding extraordinary items dropped -20.85%. Additionally, five year annualized earnings per share growth is in-line with the industry average relative to its peers.
Div yield(5 year avg)0.22%
Div growth rate (5 year)--
Payout ratio (TTM)11.17%
EPS growth(5 years)0.7148
EPS (TTM) vs
TTM 1 year ago
70.51
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.